FRM
Fox Run Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
12,891
+3,777
| +41% | +$474K | 0.27% | 64 |
|
|
2025
Q1 | $1.25M | Buy |
+9,114
| New | +$1.25M | 0.19% | 134 |
|
|
2024
Q4 | – | Sell |
-7,922
| Closed | -$1.54M | – | 876 |
|
|
2024
Q3 | $1.54M | Buy |
+7,922
| New | +$1.54M | 0.34% | 26 |
|
|
2024
Q2 | – | Sell |
-1,974
| Closed | -$426K | – | 781 |
|
|
2024
Q1 | $426K | Buy |
+1,974
| New | +$426K | 0.09% | 430 |
|
|
2023
Q3 | – | Sell |
-2,380
| Closed | -$678K | – | 714 |
|
|
2023
Q2 | $678K | Buy |
+2,380
| New | +$678K | 0.19% | 192 |
|
|
2023
Q1 | – | Sell |
-1,854
| Closed | -$513K | – | 668 |
|
|
2022
Q4 | $513K | Buy |
+1,854
| New | +$513K | 0.21% | 166 |
|
|
2022
Q3 | – | Sell |
-2,862
| Closed | -$584K | – | 606 |
|
|
2022
Q2 | $584K | Buy |
2,862
+1,255
| +78% | +$256K | 0.29% | 87 |
|
|
2022
Q1 | $338K | Buy |
+1,607
| New | +$338K | 0.19% | 225 |
|
|
2021
Q4 | – | Sell |
-707
| Closed | -$200K | – | 482 |
|
|
2021
Q3 | $200K | Buy |
+707
| New | +$200K | 0.13% | 391 |
|
|
2019
Q4 | – | Sell |
-2,394
| Closed | -$557K | – | 388 |
|
|
2019
Q3 | $557K | Buy |
2,394
+203
| +9% | +$47.2K | 0.51% | 28 |
|
|
2019
Q2 | $512K | Sell |
2,191
-79
| -3% | -$18.5K | 0.34% | 71 |
|
|
2019
Q1 | $537K | Buy |
2,270
+1,005
| +79% | +$238K | 0.3% | 89 |
|
|
2018
Q4 | $381K | Buy |
+1,265
| New | +$381K | 0.2% | 195 |
|